Invention Grant
- Patent Title: Identifying patients for intensive hyperglycemia management
-
Application No.: US17187782Application Date: 2021-02-27
-
Publication No.: US12205686B2Publication Date: 2025-01-21
- Inventor: Daniel M. Rotroff , Kevin M. Pantalone , Galen Miller-Atkins , Arshiya Mariam
- Applicant: THE CLEVELAND CLINIC FOUNDATION
- Applicant Address: US OH Cleveland
- Assignee: THE CLEVELAND CLINIC FOUNDATION
- Current Assignee: THE CLEVELAND CLINIC FOUNDATION
- Current Assignee Address: US OH Cleveland
- Agency: Tarolli, Sundheim, Covell & Tummino LLP
- Main IPC: G16H10/40
- IPC: G16H10/40 ; G16B40/00 ; G16H10/60 ; G16H15/00 ; G16H50/30
Abstract:
Systems and methods are provided for assigning a treatment to a patient is provided. A set of genetic data representing a patient. A polygenic score representing the likelihood that a patient will benefit from intensive glycemia treatment is generated from the set of genetic data. A parameter representing a response of the patient to intensive glycemia treatment is assigned according to the polygenic score.
Public/Granted literature
- US20210272661A1 IDENTIFYING PATIENTS FOR INTENSIVE HYPERGLYCEMIA MANAGEMENT Public/Granted day:2021-09-02
Information query
